Disglucemia en el paciente crítico: evidencia actual y perspectivas futuras
AUTOR(ES)
Aramendi, Ignacio, Burghi, Gastón, Manzanares, William
FONTE
Rev. bras. ter. intensiva
DATA DE PUBLICAÇÃO
2017-09
RESUMO
ABSTRACT Dysglycemia in critically ill patients (hyperglycemia, hypoglycemia, glycemic variability and time in range) is a biomarker of disease severity and is associated with higher mortality. However, this impact appears to be weakened in patients with previous diabetes mellitus, particularly in those with poor premorbid glycemic control; this phenomenon has been called "diabetes paradox". This phenomenon determines that glycated hemoglobin (HbA1c) values should be considered in choosing glycemic control protocols on admission to an intensive care unit and that patients' target blood glucose ranges should be adjusted according to their HbA1c values. Therefore, HbA1c emerges as a simple tool that allows information that has therapeutic utility and prognostic value to be obtained in the intensive care unit.
Documentos Relacionados
- Polineuropatia no paciente crítico: um diagnóstico comum em medicina intensiva?
- Infiltrado pulmonar no paciente crítico: a importância da biópsia pulmonar
- Retos y tensiones de la formación docente en el actual proceso de transformaciones
- El prejuicio racial en Brasil: nuevas medidas y perspectivas
- Desafíos y perspectivas en la investigación sobre el magisterio